D
David J. Wullimann
Researcher at Karolinska Institutet
Publications - 14
Citations - 1922
David J. Wullimann is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 2, co-authored 4 publications receiving 1080 citations. Previous affiliations of David J. Wullimann include Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
Takuya Sekine,André Perez-Potti,Olga Rivera-Ballesteros,Kristoffer Strålin,Jean Baptiste Gorin,Annika Olsson,Sian Llewellyn-Lacey,Habiba Kamal,Gordana Bogdanovic,Sandra Muschiol,David J. Wullimann,Tobias Kammann,Johanna Emgård,Tiphaine Parrot,Elin Folkesson,Olav Rooyackers,Lars Eriksson,Jan-Inge Henter,Anders Sönnerborg,Tobias Allander,Jan Albert,Morten Nielsen,Jonas Klingström,Sara Gredmark-Russ,Niklas K. Björkström,Johan K. Sandberg,David Price,Hans-Gustaf Ljunggren,Soo Aleman,Marcus Buggert +29 more
TL;DR: It is shown that SARS-CoV-2 elicits robust, broad and highly functional memory T cell responses, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19.
Posted ContentDOI
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Takuya Sekine,André Perez-Potti,Olga Rivera-Ballesteros,Kristoffer Strålin,Jean-Baptiste Gorin,Annika Olsson,Sian Llewellyn-Lacey,Habiba Kamal,Gordana Bogdanovic,Sandra Muschiol,David J. Wullimann,Tobias Kammann,Johanna Emgård,Tiphaine Parrot,Elin Folkesson,Olav Rooyackers,Olav Rooyackers,Lars Eriksson,Lars Eriksson,Anders Sönnerborg,Tobias Allander,Tobias Allander,Jan Albert,Jan Albert,Morten Nielsen,Jonas Klingström,Sara Gredmark-Russ,Niklas K. Björkström,Johan K. Sandberg,David Price,Hans-Gustaf Ljunggren,Soo Aleman,Marcus Buggert +32 more
TL;DR: The collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.
Journal ArticleDOI
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
Peter Bergman,Peter Bergman,Ola Blennow,Ola Blennow,Lotta Hansson,Lotta Hansson,Stephan Mielke,Stephan Mielke,Piotr Nowak,Piotr Nowak,Piotr Nowak,Puran Chen,Gunnar Söderdahl,Gunnar Söderdahl,Anders Österborg,Anders Österborg,C. I. Edvard Smith,David J. Wullimann,Jan Vesterbacka,Gustaf Lindgren,Lisa Blixt,Lisa Blixt,Gustav Friman,Gustav Friman,Emilie Wahren Borgström,Anna Nordlander,Angelica Cuapio Gomez,Mira Akber,Davide Valentini,Anna-Carin Norlin,Anders Thalme,Gordana Bogdanovic,Sandra Muschiol,Sandra Muschiol,Peter Nilsson,Sophia Hober,Karin Loré,Margaret Chen,Marcus Buggert,Hans-Gustav Ljunggren,Per Ljungman,Per Ljungman,Soo Aleman,Soo Aleman +43 more
TL;DR: In this paper, the authors investigated safety and efficacy of BNT162b2 mRNA vaccination in five selected groups of immunocompromised patients and healthy controls and found that the vaccine was safe.
Journal ArticleDOI
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Yutai Gao,Curtis Cai,David J. Wullimann,Julia Niessl,Olga Rivera-Ballesteros,Puran Chen,J Lange,Angelica Cuapio,Ola Blennow,Lotta Hansson,Stephan Mielke,Piotr Nowak,Jan Vesterbacka,Mira Akber,André Perez-Potti,Takuya Sekine,Thomas R. Müller,Caroline Boulouis,Tobias Kammann,Tiphaine Parrot,Jagadeeswara Rao Muvva,Michał J. Sobkowiak,Katie Healy,Gordana Bogdanovic,Sandra Muschiol,Gunnar Söderdahl,Anders Österborg,Fredrika Hellgren,Alba Grifoni,Daniela Weiskopf,Alessandro Sette,Karin Loré,Margaret Sällberg Chen,Per Ljungman,Johan Sundberg,C. I. Edvard Smith,Peter Bergman,Hans-Gustaf Ljunggren,Soo Aleman,Marcus Buggert +39 more
TL;DR: In this article , the authors assessed the single-cell profile of SARS-CoV-2-specific T cells post-mRNA vaccination in healthy individuals and patients with various forms of immunodeficiencies.
Journal ArticleDOI
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
Lisa Blixt,David J. Wullimann,Soo Aleman,Jeanette Lundin,Puran Chen,Yutai Gao,Angelica Cuapio,Mira Akber,J Lange,Olga Rivera-Ballesteros,Marcus Buggert,Hans-Gustaf Ljunggren,Lotta Hansson,Anders Österborg +13 more
TL;DR: In this article , the authors propose a method to solve the problem of "not available" data: https://www.youtube.com/watch/watch?feature=youtu.